Advertisement

Current Treatment Options in Neurology

, Volume 13, Issue 1, pp 28–40 | Cite as

Nonpharmacologic Treatments for Migraine and Tension-Type Headache: How to Choose and When to Use

  • Robert A. NicholsonEmail author
  • Dawn C. Buse
  • Frank Andrasik
  • Richard B. Lipton
Headache

Opinion statement

There are a variety of nonpharmacologic treatments for headache. Educating patients about headache and its management, identifying and managing triggers (via diaries), modifying lifestyles, and understanding the importance of adopting and adhering to interventions (either pharmacologic or nonpharmacologic) are relevant to all persons with headache. In addition, specific nonpharmacologic treatments can be used either alone or in conjunction with ongoing pharmacologic intervention. Strong candidates for nonpharmacologic treatment include individuals with significant headache-related disability, comorbid mood or anxiety disorders, difficulty managing stress or other triggers, medication overuse, and patients who prefer a specific treatment. Behavioral treatments (relaxation, biofeedback, and cognitive-behavioral therapy) possess the most evidence for successful headache management. They have a long history of randomized trials showing efficacy and are considered first-line preventive options. Among complementary and alternative treatments, recent positive findings from randomized trials using acupuncture provide evidence of its potential as a first-line intervention. Other complementary and alternative techniques do not have a consistent base of research to recommend them for headache prevention, but they may be used if the patient prefers this approach or when other first-line interventions (nonpharmacologic or pharmacologic) have not provided adequate results. Among “natural” treatments, both butterbur extract and vitamin B2 have shown efficacy in more than one randomized trial and are thus potentially useful first-line preventive interventions.

Keywords

Migraine Nonpharmacologic Intervention Headache Disorder Medication Overuse Aspartame 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Disclosure

Conflicts of interest: R. Nicholson: Member of advisory board for Merck, grant from Merck, payment for consultative services with Mercy Health Research; D. Buse: none; F. Andrasik: none; R. Lipton: Member of Advisory Board of Allergan and Merck; payment from Allergan for educational presentations or speaking; grants from GlaxoSmithKline, Allergan, Merck, and Bristol Myers Squibb.

References and recommended reading

Papers of particular interest, published recently, have been highlighted as: • Of importance; •• Of major importance

  1. 1.
    Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279:381–383.CrossRefPubMedGoogle Scholar
  2. 2.
    Lipton RB, Bigal ME, Diamond M, et al.: Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68:343–349.CrossRefPubMedGoogle Scholar
  3. 3.
    Natoli JL, Manack A, Dean B, et al.: Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010, 30:599–609.PubMedGoogle Scholar
  4. 4.
    Bigal ME, Serrano D, Reed M, Lipton RB: Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008, 71:559–566.CrossRefPubMedGoogle Scholar
  5. 5.
    Andrasik F, Flor H, Turk DC: An expanded view of psychological aspects in head pain: the biopsychosocial model. Neurol Sci 2005, 25:S87–S91.CrossRefGoogle Scholar
  6. 6.
    Holroyd KA, O’Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208–15.CrossRefPubMedGoogle Scholar
  7. 7.
    Holroyd KA, France JL, Cordingley GE, et al.: Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol 1995, 63:327–330.CrossRefPubMedGoogle Scholar
  8. 8.
    Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Neurology [serial online]. Available at: http://www.neurology.org.
  9. 9.
    Diamond S, Silberstein S, Loder E, et al.: Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache 2007, 47:355–363.PubMedGoogle Scholar
  10. 10.
    Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. US Headache Consortium 2000. Available at: http://www.aan.com/professionals/practice/pdfs/gl0089.pdf. Accessed October 25, 2010.
  11. 11.
    Hahn SR: Communication in the care of the headache patient. In Wolff’s Headache and Other Head Pain. By Silberstein SD, Lipton RL, Dodick DW. New York: Oxford University Press; 2008:805–824.Google Scholar
  12. 12.
    Martin VT: Simplifying the diagnosis of migraine headache. Adv Stud Med 2004, 4:200–207.Google Scholar
  13. 13.•
    Buse DC, Andrasik F: Behavioral medicine for migraine. Neurol Clin 2009, 27:321–329.CrossRefGoogle Scholar
  14. 14.•
    Nicholson RA: Chronic headache: the role of the psychologist. Curr Pain Headache Rep 2010, 14:47–54.CrossRefPubMedGoogle Scholar
  15. 15.
    Kelman L: The triggers or precipitants of the acute migraine attack. Cephalalgia 2007, 27:394–402.CrossRefPubMedGoogle Scholar
  16. 16.
    Martin VT, Behbehani MM: Toward a rational understanding of migraine trigger factors. Med Clin North Am 2001, 85:911–941.CrossRefPubMedGoogle Scholar
  17. 17.
    Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Cephalalgia 2001, 21:554–558.Google Scholar
  18. 18.•
    Martin PR: Behavioral management of migraine headache triggers: learning to cope with triggers. Curr Pain Headache Rep 2010, 14:221–227.CrossRefPubMedGoogle Scholar
  19. 19.
    Nicholson R, Nash J, Andrasik F: A self-administered behavioral intervention using tailored messages for migraine. Headache 2005, 45:1124–1139.CrossRefPubMedGoogle Scholar
  20. 20.•
    Sauro KM, Becker WJ: The stress and migraine interaction. Headache 2009, 49:1378–1386.CrossRefPubMedGoogle Scholar
  21. 21.
    Rime C, Andrasik F: Relaxation techniques and guided imagery. In Pain Management, Vol. 2, 2nd Edition. Edited by Waldman SD. Philadelphia: Saunders/Elsevier. 2011 (in press).Google Scholar
  22. 22.
    Goslin RE, Gray RN, McCrory DC, et al.: Behavioral and Physical Treatments for Migraine Headache. Technical Review 2.2. February 1999. (Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025. Available from the National Technical Information Service; NTIS Accession No. 127946.)Google Scholar
  23. 23.
    McCrory DC, Penzien, DB, Hasselblad V, et al.: Evidence Report: Behavioral and Physical Treatments for Tension-type and Cervicogenic Headache. Des Moines, IA: Foundation for Chiropractic Education and Research (Product No. 2085). 2001Google Scholar
  24. 24.
    Schwartz MS, Andrasik F (eds.): Biofeedback: A Practitioner’s Guide, edn 3rd. New York: Guilford Press; 2003.Google Scholar
  25. 25.
    Andrasik F, Rime C: Can behavioural therapy influence neuromodulation? Neurological Sciences 2007, 28:S124–S129.CrossRefPubMedGoogle Scholar
  26. 26.•
    Nestoriuc Y, Martin A, Rief W, Andrasik F: Biofeedback treatment for headache disorders: A comprehensive efficacy review. Applied Psychophysiology and Biofeedback 2008, 33:125–140.CrossRefPubMedGoogle Scholar
  27. 27.•
    Holroyd KA, Labus JS, Carlson B: Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain 2009, 143:213–222.CrossRefPubMedGoogle Scholar
  28. 28.•
    Seng EK, Holroyd KA. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Ann Behav Med 2010 Sep 2 (Epub ahead of print). This article helps to delineate how cognitive factors are important in headache.Google Scholar
  29. 29.
    Nicholson RA, Houle TT, Rhudy JL, Norton PJ: Psychological risk factors in headache. Headache 2007, 47:413–426.PubMedGoogle Scholar
  30. 30.
    Grazzi L, Andrasik F, D’Amico D, et al.: Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at three years. Headache 2002, 42:483–490.CrossRefPubMedGoogle Scholar
  31. 31.•
    Whitmarsh T, Buse DC. Biobehavioral, complementary, and alternative treatments for headache. In Handbook of Headache. Edited by Martelletti P, Steiner TJ (in press). New York: Springer.This is a broad comprehensive overview of CAM and headache. Google Scholar
  32. 32.
    Diener HC, Kronfeld K, Boewing G, et al.: Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomized controlled clinical trial. Lancet Neurology 2006, 5:310–316.CrossRefPubMedGoogle Scholar
  33. 33.
    Linde K, Streng A, Jürgens S, et al.: Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005, 293:2118–2125.CrossRefPubMedGoogle Scholar
  34. 34.
    Melchart D, Streng A, Hoppe A, et al.: Acupuncture in patients with tension-type headache: randomized controlled trial. BMJ 2005, 331:376–382.CrossRefPubMedGoogle Scholar
  35. 35.
    Streng A, Linde K, Hoppe A, et al.: Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache 2006, 46:1492–1502.CrossRefPubMedGoogle Scholar
  36. 36.
    Biondi DM: Physical treatments for headache: A structured review. Headache 2005, 45:738–746.CrossRefPubMedGoogle Scholar
  37. 37.
    Brønfort G, Nilsson N, Haas M, et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001878.Google Scholar
  38. 38.
    Lawler SP, Cameron LD: A randomized controlled trial of massage therapy as a treatment for migraine. Ann Behav Med 2006, 32:50–59.CrossRefPubMedGoogle Scholar
  39. 39.
    Bhatia R, Dureja GP, Tripathi M, et al.: Role of temporalis muscle over activity in chronic tension type headache: effect of yoga based management. Indian J Physiol Pharmacol 2007, 51:333–344.PubMedGoogle Scholar
  40. 40.
    John PJ, Sharma N, Sharma CM, Kankane A: Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache 2007, 47:654–661.CrossRefPubMedGoogle Scholar
  41. 41.
    Ernst E: Homeopathic prophylaxis of headaches and migraine? A systematic review. Journal of Pain & Symptom Management 1999, 18:353–357.CrossRefGoogle Scholar
  42. 42.
    Evans RW, Taylor FR: “Natural” or alternative medications for migraine prevention. Headache 2006, 46:1012–1018.CrossRefPubMedGoogle Scholar
  43. 43.
    Diener HC, Rahlfs VW, Danesch U: The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: Reanalysis of efficacy criteria. Eur Neurol 2004, 51:89–97.CrossRefPubMedGoogle Scholar
  44. 44.
    Lipton RB, Gobel H, Einhaupl KM, et al.: Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004, 63:2240–2244.PubMedGoogle Scholar
  45. 45.
    Maizels M, Blumenfeld A, Burchette R: A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: A randomized trial. Headache 2004, 44:885–890.CrossRefPubMedGoogle Scholar
  46. 46.
    Schoenen J, Jacquy J, Lenaerts M: Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998, 50:466–470.PubMedGoogle Scholar
  47. 47.
    Sándor S, Di Clemente L, Coppola G, et al.: Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology 2005, 64:713–720.PubMedGoogle Scholar
  48. 48.•
    Bartsch T, Paemeleire K, Goadsby PJ: Neurostimulation approaches to primary headache disorders. Curr Opin Neurol 2009, 22:262–268.CrossRefPubMedGoogle Scholar
  49. 49.•
    Tepper SJ, Cleves C, Taylor FR: Patent foramen ovale and migraine: association, causation, and implications of clinical trials. Curr Pain Headache Rep 2009, 13:221–226.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Robert A. Nicholson
    • 1
    • 4
    Email author
  • Dawn C. Buse
    • 2
  • Frank Andrasik
    • 3
  • Richard B. Lipton
    • 2
  1. 1.Department of Neurology & PsychiatrySaint Louis University School of MedicineSt. LouisUSA
  2. 2.Department of Neurology, Albert Einstein College of MedicineMontefiore Headache CenterBronxUSA
  3. 3.Department of PsychologyUniversity of MemphisMemphisUSA
  4. 4.Ryan Headache CenterMercy Health ResearchSt. LouisUSA

Personalised recommendations